Mahmoud E S Soliman

InstitutionUniversity of Kwazulu-Natal
AddressSouth Africa
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 2 publications in October 2020 and November 2020
    All Publications
    Bar chart showing 89 publications over 13 distinct years, with a maximum of 18 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rudrapal M, Issahaku AR, Agoni C, Bendale AR, Nagar A, Soliman MES, Lokwani D. In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2. J Biomol Struct Dyn. 2021 Jun 28; 1-17. PMID: 34182889.
      Citations: 2     Fields:    
    2. Olotu FA, Omolabi KF, Soliman MES. Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex. Cell Biochem Biophys. 2021 Jun; 79(2):175-187. PMID: 33792836.
      Citations: 3     Fields:    Translation:HumansCells
    3. Agoni C, Soliman MES. The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment. Curr Pharm Biotechnol. 2021; 22(11):1520-1537. PMID: 33109039.
      Citations: 1     Fields:    Translation:Humans
    4. Al-Sehemi AG, Olotu FA, Dev S, Pannipara M, Soliman ME, Soliman ME, Carradori S, Mathew B. Natural Products Database Screening for the Discovery of Naturally Occurring SARS-Cov-2 Spike Glycoprotein Blockers. ChemistrySelect. 2020 Nov 13; 5(42):13309-13317. PMID: 33363254.
      Citations: 2     
    5. Soremekun OS, Omolabi KF, Adewumi AT, Soliman ME. Exploring the effect of ritonavir and TMC-310911 on SARS-CoV-2 and SARS-CoV main proteases: potential from a molecular perspective. Future Sci OA. 2020 Nov 09; 7(1):FSO640. PMID: 33432269.
      Citations:    
    6. Ogidigo JO, Iwuchukwu EA, Ibeji CU, Okpalefe O, Soliman MES. Natural phyto, compounds as possible noncovalent inhibitors against SARS-CoV2 protease: computational approach. J Biomol Struct Dyn. 2022 Mar; 40(5):2284-2301. PMID: 33103616.
      Citations: 2     Fields:    
    7. Olotu FA, Omolabi KF, Soliman MES. Leaving no stone unturned: Allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain. Inform Med Unlocked. 2020; 21:100451. PMID: 33083517.
      Citations: 5     
    8. Dwarka D, Agoni C, Mellem JJ, Soliman ME, Soliman ME, Baijnath H. Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches. S Afr J Bot. 2020 Sep; 133:273-284. PMID: 32839635.
      Citations: 2     
    9. Soremekun OS, Omolabi KF, Soliman MES. Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells. Inform Med Unlocked. 2020; 20:100384. PMID: 32835074.
      Citations: 4